Table 1 Main Conclusions From the Recent Review on the Safety And Effectiveness of PHO by the European Medicines Agency's Committee for Medicinal Products for Human Use [2]
From: The pholcodine Case. Cough Medicines, IgE-Sensitization, and Anaphylaxis: A Devious Connection
1 | The benefits of pholcodine continue to outweigh its risks |
2 | No new risks have been identified with pholcodine |
3 | Although a cross-sensitization between pholcodine and NMBA is biologically plausible, the available data are weak and not fully consistent |
4 | Patients taking pholcodine-containing medicines can continue to do so |